Mechanistic Insight into the Inhibition of Choline Acetyltransferase by Proton Pump Inhibitors.
Alzheimer’s disease
MM-PBSA
PET-ligands
choline-acetyltransferase
dementia
molecular docking
molecular dynamics
neurodegenerative disorder
proton pump inhibitors
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
15 02 2023
15 02 2023
Historique:
pubmed:
8
2
2023
medline:
17
2
2023
entrez:
7
2
2023
Statut:
ppublish
Résumé
Various pharmacoepidemiological investigational studies have indicated that Proton Pump Inhibitors (PPIs) may increase the likelihood of developing Alzheimer's disease (AD) and non-AD related dementias. Previously, we have reported the inhibition of the acetylcholine biosynthesizing enzyme choline acetyltransferase (ChAT) by PPIs, for which omeprazole, lansoprazole, and pantoprazole exhibited IC
Identifiants
pubmed: 36749117
doi: 10.1021/acschemneuro.2c00738
doi:
Substances chimiques
Proton Pump Inhibitors
0
Choline O-Acetyltransferase
EC 2.3.1.6
Omeprazole
KG60484QX9
Cholinergic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM